Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients.

Autor: Qin CX; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD., Moore LW; Department of Surgery, Houston Methodist Hospital, Houston, TX., Anjan S; Division of Infectious Disease, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL., Rahamimov R; Department of Nephrology and Hypertension, Rabin Medical Center, Petah-Tikva, Israel., Sifri CD; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA., Ali NM; Transplant Institute, NYU Langone Health, New York, NY., Morales MK; Division of Infectious Diseases, Department of Internal Medicine, Virginia Commonwealth University Health, Richmond, VA., Tsapepas DS; Department of Surgery, Columbia University College of Physicians and Surgeons, New York, NY., Basic-Jukic N; Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Clinical Hospital Centre Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia., Miller RA; Division of Infectious Diseases, Department of Medicine, Duke University, Durham, NC., van Duin D; Division of Infectious Diseases, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC., Santella RN; Avera Medical Group Nephrology, Avera McKennan Hospital and University Health Center, Sioux Falls, SD., Wadei HM; Department of Transplant, Mayo Clinic, Jacksonville, FL., Shah PD; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD., Gage N; Virginia Transplant Center at Henrico Doctors' Hospital, Henrico, VA., Malinis M; Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT., Aslam S; Division of Infectious Diseases & Global Public Health, Department of Medicine, University of California San Diego, San Diego, CA., Todesco E; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé publique (iPLESP), APHP, Hôpital Pitié-Salpêtrière, Paris, France., Werbel WA; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD., Avery RK; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD., Segev DL; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Jazyk: angličtina
Zdroj: Transplantation [Transplantation] 2021 Nov 01; Vol. 105 (11), pp. e265-e266.
DOI: 10.1097/TP.0000000000003907
Abstrakt: Competing Interests: D.L.S. received honoraria for consulting and speaking from Sanofi, Novartis, CSL Behring, Jazz Pharmaceuticals, Veloxis, Mallinckrodt, and Thermo Fisher Scientific. R.K.A has received study/grant support from Aicuris, Astellas, Chimerix, Merck, Oxford Immunotec, Qiagen, and Takeda/Shire. S.A. received grant support from the Cystic Fibrosis Foundation, received consulting honoraria from Merck and Gilead, and was an unpaid consultant for BioMX. The other authors declare no conflicts of interest.
Databáze: MEDLINE